FDA to medical device manufacturers: ‘Get your house in order’

The US Food and Drug Administration (FDA) is addressing medical device security issues by requiring manufacturers to employ security features from the outset and providing decision-makers with software bill of materials (SBOMs). The changes, due by October, will not immediately affect legacy devices but will help digital innovation in cybersecurity. The FDA now has regulatory oversight of these security aspects, which has been noted positively by medical industry commentators.